News for Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics (SNSE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

**media[509217]**

BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. ( SNSE), a clinical stage biotechnology company focused on the discovery and developmen

**media[477953]**

**media[450045]**

Shares of iRhythm Technologies, Inc. IRTC rose sharply in today's pre-market trading after the company announced that it was granted FDA clearance for its 510(k...

Sensei Biotherapeutics names new financial chief

- Promising Phase 1/2 SNS-101 clinical data presented at ASCO 2024 - - Enrollment in the Phase 1 dose expansion of SNS-101 clinical trial advancing...

SNS-101 Topline Monotherapy & Combination Dose Escalation Data June 3, 2024 Presenters: ...

Conditionally Active Antibodies for Immuno-oncology Corporate Deck | June 2024 Disclaimer This presentation...

BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery...

The cervical dysplasia market is expected to grow significantly owing to an increased screening rate and increasing initiatives to create public awareness....

The cervical cancer market is expected to grow due to factors like an increase in the patient pool, rising awareness of the disease, an increase in...

Nanobody Market Trends and Insights by Type (Mono-specific and Multi-specific), by Application (Therapeutic [Cancer, Neurodegenerative Diseases, Infectious...

Read Stock Analysts’ Upgrades for May 24th (CLBS, OMAB, PKOH, SNSE, SPPI, SRZN, SUI, SURVF, SWIR, SWMAY) at ETF Daily News

Read Equities Research Analysts’ Downgrades for May 21st (ASRT, CCNE, KOPN, KTB, KTOS, LABP, LSF, MASS, MDWD, MOR) at ETF Daily News

Read Research Analysts’ Upgrades for May 17th (ADSK, AMD, APTV, ATRC, AZZ, BALL, BLL, BY, COO, DLVHF) at ETF Daily News

Read Reviewing Adhera Therapeutics (OTCMKTS:ATRX) and Sensei Biotherapeutics (NASDAQ:SNSE) at ETF Daily News

During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding ...